Advertisement

Pediatric Surgery International

, Volume 30, Issue 5, pp 493–497 | Cite as

Morbidity and mortality associated with liver resections for primary malignancies in children

  • Nathan P. ZwintscherEmail author
  • Kenneth S. Azarow
  • John D. Horton
Original Article

Abstract

Purpose

Liver resection (LR) is a high-risk procedure with limited data in the pediatric surgical literature regarding short-term outcomes. Our aim was to characterize the patient population and short-term outcomes for children undergoing LR for malignancy.

Methods

We studied 126 inpatient admissions for children ≤20 years of age undergoing LR in 2009 using the Kids′ Inpatient Database. Patients had a principal diagnosis of a primary hepatic malignancy and LR listed as one of the first five procedures. Transplantations were excluded. Complications were defined by ICD-9 codes. High-volume centers performed at least 5 LR.

Results

The mean age was 5.83 years. The morbidity and mortality rates were 30.7 and 3.7 %, respectively. The most common causes of morbidity were digestive system complications (7.4 %), anemia (7.3 %), and respiratory complications (3.8 %). 43.9 % received a blood product transfusion. The average length of stay was 10.04 days. When compared to low-volume centers, high-volume centers increased the likelihood of a complication fourfold (P = 0.011) but had 0 % mortality (P = 0.089).

Conclusion

LR remains a procedure fraught with multiple complications and a significant mortality rate. High-volume centers have a fourfold increase in likelihood of complications compared to low-volume centers and may be related to extent of hepatic resection.

Keywords

Liver resection Hepatic malignancy Complications Children 

Notes

Conflict of interest

No authors have any significant disclosures related to this manuscript or its publication.

References

  1. 1.
    Honeyman JN, La Quaglia MP (2012) Malignant liver tumors. Semin Pediatr Surg 21:245–254PubMedCrossRefGoogle Scholar
  2. 2.
    Franchi-Abella S, Branchereau S (2013) Benign hepatocellular tumors in children: focal nodular hyperplasia and hepatocellular adenoma. Int J Hepatol 2013:215064PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Agarwala S (2012) Primary malignant liver tumors in children. Indian J Pediatr 79:793–800PubMedCrossRefGoogle Scholar
  4. 4.
    von Schweinitz D (2006) Management of liver tumors in childhood. Semin Pediatr Surg 15:17–24CrossRefGoogle Scholar
  5. 5.
    Childhood Cancer Statistics (2013) American Childhood Cancer Organization. http://www.acco.org/Information/AboutChildhoodCancer/ChildhoodCancerStatistics.aspx. Accessed 27 Jun 2013
  6. 6.
    Ismail H, Broniszczak D, Kalicinski P, Dembowska-Baginska B, Perek D, Teisseyre J, Kluge P, Kosciesza A, Lembas A, Markiewicz M (2012) Changing treatment and outcome of children with hepatoblastoma: analysis of a single center experience over the last 20 years. J Pediatr Surg 47:1331–1339PubMedCrossRefGoogle Scholar
  7. 7.
    Kim T, Kim DY, Cho MJ, Kim SC, Seo JJ, Kim IK (2011) Surgery for hepatoblastoma: from laparoscopic resection to liver transplantation. Hepatogastroenterology 58:896–899PubMedCrossRefGoogle Scholar
  8. 8.
    Murphy AJ, Rauth TP, Lovvorn HN 3rd (2012) Chronic biloma after right hepatectomy for stage IV hepatoblastoma managed with Roux-en-Y biliary cystenterostomy. J Pediatr Surg 47:e5–e9PubMedCentralPubMedCrossRefGoogle Scholar
  9. 9.
    Schnater JM, Aronson DC, Plaschkes J, Perilongo G, Brown J, Otte JB, Brugieres L, Czauderna P, MacKinlay G, Vos A (2002) Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group. Cancer 94:1111–1120PubMedCrossRefGoogle Scholar
  10. 10.
    Grazia Scuderi M, Magro G, Cataldo AD, Pesce A, Scalora L, Vecchio GM, Portale R, Benedetto VD, Puleo S (2013) Evaluation of neoadjuvant chemotherapy effects on liver parenchyma in resected pediatric malignancies. Pediatr Hematol Oncol 30:392–399PubMedCrossRefGoogle Scholar
  11. 11.
    HCUP Kids’ Inpatient Database (KID). Healthcare Cost and Utilization Project (HCUP) (2009) Agency for Healthcare Research and Quality, Rockville. www.hcup-us.ahrq.gov/kidoverview.jsp. Accessed 8 Jan 2012
  12. 12.
    Tracy ET, Bennett KM, Danko ME, Diesen DL, Westmoreland TJ, Kuo PC, Pappas TN, Rice HE, Scarborough JE (2010) Low volume is associated with worse patient outcomes for pediatric liver transplant centers. J Pediatr Surg 45:108–113PubMedCrossRefGoogle Scholar
  13. 13.
    Meyers RL, Czauderna P, Otte JB (2012) Surgical treatment of hepatoblastoma. Pediatr Blood Cancer 59:800–808PubMedCrossRefGoogle Scholar
  14. 14.
    Tajiri T, Kimura O, Fumino S, Furukawa T, Iehara T, Souzaki R, Kinoshita Y, Koga Y, Suminoe A, Hara T, Kohashi K, Oda Y, Hishiki T, Hosoi H, Hiyama E, Taguchi T (2012) Surgical strategies for unresectable hepatoblastomas. J Pediatr Surg 47:2194–2198PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg (outside the USA) 2014

Authors and Affiliations

  • Nathan P. Zwintscher
    • 1
    Email author
  • Kenneth S. Azarow
    • 2
  • John D. Horton
    • 1
  1. 1.Department of SurgeryMadigan Army Medical CenterTacomaUSA
  2. 2.Department of SurgeryOregon Health and Science UniversityPortlandUSA

Personalised recommendations